Showing results (741-750 of 1,395) with videos related to
Sort By:
Pageof 140
JCO Precision Oncology|February 9, 2022
Phase I Trial of Dabrafenib and Pazopanib in BRAF Mutated Advanced MalignanciesSigurdis Haraldsdottir, Filip Janku, Ming Poi, et al.JCO Precision Oncology|February 9, 2022
Deleterious Pulmonary Surfactant System Gene Mutations in Lung Adenocarcinomas Associated With Usual Interstitial PneumoniaTakayuki Honda, Hiroyuki Sakashita, Kyohei Masai, et al.JCO Precision Oncology|February 9, 2022
Comparison of Treatment Recommendations by Molecular Tumor Boards WorldwideDamian T Rieke, Mario Lamping, Marissa Schuh, et al.JCO Precision Oncology|February 9, 2022
Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United StatesAndrew N Freedman, Carrie N Klabunde, Kristine Wiant, et al.JCO Precision Oncology|February 9, 2022
Circulating BRAF V600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid CarcinomaPriyanka C Iyer, Gilbert J Cote, Tao Hai, et al.JCO Precision Oncology|February 2, 2022
Distinct Genomic Landscapes in Early-Onset and Late-Onset Endometrial CancerJungyoon Choi, Andreana N Holowatyj, Mengmeng Du, et al.JCO Precision Oncology|June 11, 2019
5-Hydroxymethylcytosine Profiles Are Prognostic of Outcome in Neuroblastoma and Reveal Transcriptional Networks That Correlate With Tumor PhenotypeMark A Applebaum, Erin K Barr, Jason Karpus, et al.JCO Precision Oncology|September 29, 2021
Underdiagnosis of Hereditary Colorectal Cancers Among Medicare Patients: Genetic Testing Criteria for Lynch Syndrome Miss the MarkCharles Muller, Sarah M Nielsen, Kathryn E Hatchell, et al.JCO Precision Oncology|October 11, 2021
Clinical Outcomes of Molecular Tumor Boards: A Systematic ReviewKara L Larson, Bin Huang, Heidi L Weiss, et al.JCO Precision Oncology|October 11, 2021
Patients' Expectations of Benefits From Large-Panel Genomic Tumor Testing in Rural Community Oncology PracticesEric C Anderson, John DiPalazzo, Emily Edelman, et al.Pageof 140